BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Staging
4 results:

  • 1. N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD.
    Tang LJ; Li G; Eslam M; Zhu PW; Chen SD; Leung HH; Huang OY; Wong GL; Zhou YJ; Karsdal M; Leeming DJ; Jiang P; Wang C; Yuan HY; Byrne CD; Targher G; George J; Wong VW; Zheng MH
    Hepatol Int; 2023 Feb; 17(1):190-201. PubMed ID: 36152131
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Validation of the 8th AJCC cancer staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
    You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
    Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.
    Kitai S; Kudo M; Izumi N; Kaneko S; Ku Y; Kokudo N; Sakamoto M; Takayama T; Nakashima O; Kadoya M; Matsuyama Y; Matsunaga T
    Dig Dis; 2014; 32(6):717-24. PubMed ID: 25376289
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.